MSC INDUSTRIAL SUPPLY CO. INVESTOR PRESENTATION FISCAL 2026 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Statements in this presentation may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact, that address activities, events or developments that MSC expects, believes or anticipates will or may occur in the future, including statements about results of operations and financial conditio ...

Debt Investor Presentation 6 January 2026 Contents 2 ▪ DNB – A brief overview ▪ The Norwegian economy ▪ Financial targets, performance and capital ▪ Loan book and asset quality ▪ ESG and sustainability ▪ Funding ▪ Appendices: ▪ Green bond framework ▪ Cover pool portfolio information and LCR eligibility ▪ ESG and digitalisation DNB – A brief overview 3 Jan - Sept 2025 Highlights ▪ Impairments NOK -1 950 mill 4 ▪ Resilient and solid earnings ▪ Pre-tax operating profit before impairment NOK 41 979 mill ▪ Profi ...

AI Market and Applications - AI is pervasive, with an estimated 5 billion people using AI daily within 5 years[14] - AI is expanding from cloud to personal computing and edge devices[18] - AI model innovation is accelerating compute demand, with training flops increasing 4x every year[28] AMD's AI Solutions for Data Center - AMD is building a blueprint for yotta scale infrastructure[31] - The AMD "Helios" AI Rack features 2.9 Exaflops of AI compute, 31 TB of HBM4 memory, and 43 TB/s scale out bandwidth[38] - AMD Instinct MI455X offers a 10x performance increase compared to MI355X[40] - AMD is extending its leadership roadmap with the next-gen MI500 series, targeting a >1000x AI performance increase in 4 years[52] AMD's AI Solutions for PCs - AMD is at the forefront of AI PC innovation, introducing the first x86 NPU[60] - AMD Ryzen AI 400 Series powers next-generation AI PCs, offering up to 1.3x faster multitasking and 1.7x faster content creation compared to Intel Core Ultra 9 288V[66] - AMD Ryzen AI Max+ demonstrates up to 1.4x faster AI performance compared to Apple Macbook Pro M5[77] and up to 1.8x faster content creation[78] - AMD Ryzen AI Max+ achieves up to 1.7x-1.8x tokens/sec per dollar compared to Nvidia DGX Spark in AI development tasks[81] AMD's Broader Impact - AMD powers over 1 billion gamers & creators[90] - AMD is the compute foundation for modern science, contributing to climate forecasting with an 85% reduction in time to generate forecasts[111] and antibody optimization[119]

Open Model Ecosystem - NVIDIA leads the open model ecosystem [14, 100] - 80% of startups are building on open models [10] - 1-in-4 OpenRouter tokens are generated by open models [10] AI Performance and Benchmarks - NVIDIA's Llama Nemotron Nano VL 8B achieves 70.2% in Text 4 Recognition, 69.1% in Text 4 Referring, 61.8% in Text 4 Spotting, 81.4% in Relation 4 Extraction, 39.2% in Element A Parsing, 31.9% in Mathematical 4 Calculation, and 73.1% in Visual Unders A [20] - nvidia/canary-gwen-2.5b achieves an average WER of 5.63 [26] New NVIDIA Technologies - NVIDIA announces Alpamayo, an open reasoning VLA for autonomous vehicles [61, 65] - NVIDIA ships full-stack AV on 2025 Mercedes Benz CLA [68] - NVIDIA Vera CPU features 88 custom Olympus cores, 176 threads, 1.8 TB/s NVLink-C2C, 1.5 TB system memory, 1.2 TB/s LPDDR5X, and 227 billion transistors [120] - NVIDIA Rubin GPU offers 50 PFLOPS NVFP4 Inference (5X Blackwell), 35 PFLOPS NVFP4 Training (3.5X), 22 TB/s HBM4 Bandwidth (2.8X), 3.6 TB/s NVLink Bandwidth per GPU (2X), and 336 billion transistors (1.6X) [122] - NVIDIA ConnectX-9 Spectrum-X SuperNIC provides 800 Gb/s Ethernet, programmable RDMA, line-speed encryption, and 23 billion transistors [125] - NVIDIA BlueField-4 offers 800G Gb/s DPU, 64 Core Grace CPU, 6X Compute, 2X Networking, 3X Memory BW, and 126 Billion Transistors [127] - NVIDIA NVLink 6 Switch scales up fabric with 3.6 TB/s per-GPU bandwidth and 108 billion transistors [131] - NVIDIA Vera Rubin NVL72 achieves 3.6 EFLOPS NVFP4 Inference (5X Blackwell), 2.5 EFLOPS NVFP4 Training (3.5X), 54 TB LPDDR5X Capacity (3X), 20.7 TB HBM Capacity (1.5X), 1.6 PB/s HBM4 Bandwidth (2.8X), 260 TB/s Scale-Up Bandwidth (2X), and 220 Trillion Transistors (1.7X) [134] - NVIDIA Spectrum-X Ethernet Co-Packaged Optics scales to 102.4 Tb/s with 200G silicon photonics and 352 billion transistors [136]

Company Overview - Whitecap's market capitalization is approximately $14 billion[9] and enterprise value is around $17 billion[13] - The company's 2026 production guidance is 372,500 boe/d[9], with an expected funds flow of $3.3 billion[9] and a capital budget of $2.05 billion[9] - Whitecap targets a total shareholder return of 10%-15% annually[14] Financial Strength - The company has a low leverage ratio of approximately 1.0x Net Debt / Funds Flow[9] and an investment-grade credit rating of BBB by DBRS[18] - Whitecap has $3.3 billion in net debt[28], with 50% fixed interest rate debt and 50% variable interest rate debt[28] - The company targets a payout ratio of 20%-25% for its base dividend[20], with an annual dividend of $0.73 per share[9] Asset Portfolio - Whitecap has a diversified asset base with approximately 10,500 inventory locations, split between 55% conventional and 45% unconventional[35] - The company holds approximately 1,500,000 acres of Montney & Duvernay rights[43] and has approximately 4,700 Montney & Duvernay locations in inventory[43] - The company estimates 5,800 primarily light oil conventional drilling locations[17]

NMRA-511 Phase 1b Study Results - NMRA-511 Phase 1b study is for Alzheimer's Disease (AD) Agitation [2] - The company is focused on redefining neuroscience drug development [4] - Alzheimer's disease affects approximately 7 million U S adults in 2024, and this number is expected to increase to 13 million by 2050 [12] - Over 70% of people with Alzheimer's Disease experience agitation at some point [12] - NMRA-511 demonstrated a 15 7-point reduction in CMAI total score at Week 8 [47] NMRA-511 Clinical Trial and Safety - In the NMRA-511 Phase 1b study, 40 participants were in the NMRA-511 group and 40 in the placebo group [45] - 45% of the NMRA-511 group were male, compared to 37 5% in the placebo group [45] - 67 5% of the NMRA-511 group were White, compared to 75% in the placebo group [45] - Protocol-defined medication non-adherence was observed in 17 5% of the NMRA-511 group [45] - The company plans to initiate a multiple ascending dose extension in 2026 to enable higher dosing [61]

Company Overview - Whitecap's market capitalization is approximately $14 Billion[3] - The company's 2026 production guidance is 372,500 boe/d[3] - Whitecap anticipates $3.3 Billion in funds flow for 2026[3] - The 2026 capital budget is projected at $2.05 Billion[3] - Net debt as of September 30th, 2025, was $3.3 Billion, with a Net Debt / Funds Flow ratio of 1.0x[3] - The annual dividend is $0.73 per share ($0.0608/month)[3] Strategy and Operations - The company targets a total shareholder return of 10%-15% annually[8] - Whitecap plans for 3%-5% per share production growth per annum, dependent on commodity prices[14] - The company aims for a base dividend payout ratio of 20%-25%[14] - Whitecap's 2026 budget anticipates 3% production growth[22] - At a WTI price of US$60/bbl, 2026 funds flow sensitivity is $3.3 Billion[22] - At a WTI price of US$60/bbl, the company plans to allocate $2.1 Billion to capital budget, $0.9 Billion to base dividend and $0.3 Billion to share repurchases/debt reduction[26]

Transaction Overview - OceanFirst Financial Corp 将以全股票方式收购 Flushing Financial Corporation，每股 Flushing 股票兑换 0.8500 股 OceanFirst 股票[42] - Warburg Pincus 将投资 2.25 亿美元用于 OceanFirst 的股权融资，购买价格为每股 19.76 美元[14, 42] - 交易完成后，OceanFirst 股东预计将持有合并后公司约 58% 的股份，Flushing 股东持有约 30%，Warburg Pincus 持有约 12%[42] Financial Impact - 预计 2027 年每股收益 (EPS) 将增加 16%[17, 34] - 有形账面价值 (TBV) 稀释为 (6%)，预计 3.1 年内收回[17, 34] - 预计 2027 年有形普通股报酬率 (ROATCE) 为 12.6%，普通资产报酬率 (ROAA) 为 1.00%[17, 34] Strategic Rationale - 通过 Flushing 在长岛和纽约市的渠道，OceanFirst 能够扩展其产品和服务[14] - 合并后的银行预计总资产将达到 230 亿美元[17, 34] - 合并有助于贷款组合多元化，并降低商业房地产 (CRE) 集中度[14] Risk and Cautionary Notes - 该报告包含前瞻性陈述，涉及风险和不确定性，实际结果可能与预测存在重大差异[4, 5] - 风险包括交易完成的延迟或失败，监管批准的条件，以及整合两家公司业务的潜在困难[5]

Financial Performance - Revenue for Q3 2025 was $14.3 million, compared to $15.2 million in Q3 2024[7] - Like-for-like revenue (excluding discontinued product lines) was $14.2 million in Q3 2025, compared to $14.6 million in Q3 2024[4, 7] - Gross profit increased to $6.5 million in Q3 2025 from $5.3 million in Q3 2024, with gross margin improving to 45.2% from 35.0%[7] - The company achieved positive Adjusted EBITDA of $0.5 million for the quarter, compared to negative $1.4 million in Q3 2024[4] - Net loss was $5.1 million in Q3 2025, compared to $4.8 million in Q3 2024[4] - Basic and diluted loss per ADS was $0.28 in Q3 2025, compared to $0.46 in Q3 2024[4] Key Revenue Drivers - TrinScreen HIV sales were $1.0 million in Q3 2025, compared to $2.4 million in Q3 2024, reflecting the resumption of manufacture[7] - UniGold HIV sales showed strong performance with sales of $2.6 million in Q3 2025, compared to $1.6 million in Q3 2024[7] - Haemoglobin revenue increased to $5.7 million in Q3 2025 from $5.1 million in Q3 2024[7] Expenses and Liquidity - R&D expense was $0.8 million in Q3 2025, compared to $1.0 million in Q3 2024[10] - SG&A expense decreased to $6.2 million in Q3 2025 from $6.5 million in Q3 2024[10] - Cash balance at the end of Q3 2025 was $1.3 million, compared to $2.8 million in Q3 2024[10]

2025Q3 Performance Highlights - Hotel RevPAR was RMB 124, down 84% compared with 2024Q3[14] - Restaurant Average Daily Sales Per Store (ADS) was RMB 3,714, down 241% compared with 2024Q3[14] - Hotel Revenues were RMB 2545 million, down 113% compared with 2024Q3[14] - Hotel Income from Operations was RMB 691 million, down 305% with a margin of 272% compared with 2024Q3[14] - Adjusted Income from Operations was RMB 1093 million, up 36% with a margin of 405% compared with 2024Q3[14] - Net Income was RMB 595 million, up 15% with a margin of 234% compared with 2024Q3[14] - Adjusted Net Income was RMB 905 million, up 57% with a margin of 284% compared with 2024Q3[14] - Adjusted EBITDA was RMB 1150 million, down 61% with a margin of 379% compared with 2024Q3[14] Strategic Execution - Further Expansion into Mid-to-Upscale Segment[43] - Greater Penetration in Tier 3 and Lower Cities in South China[43]